Pliant Therapeutics, Inc. · NASDAQ:PLRX
Deep Track Capital, LP reported a 6.43% stake in Pliant Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Deep Track Capital, LP reported a 6.43% stake in Pliant Therapeutics, Inc., 3,947,807 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 6.43%
- Shares
- 3,947,807
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 6.43% | 3,947,807 |
| Deep Track Biotechnology Master Fund, Ltd. | 6.43% | 3,947,807 |
| David Kroin | 6.43% | 3,947,807 |
Source
Related
- Pliant Therapeutics, Inc.
- Deep Track Capital, LP
- Pliant Therapeutics, Inc. shareholders
- Schedule 13G/A · Deep Track Capital, LP · Nov 14, 2025
- Schedule 13G/A · Citadel Advisors LLC · Aug 14, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Woodline Partners LP · Feb 17, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Feb 17, 2026
- Schedule 13G · Citadel Advisors LLC · Feb 9, 2026